Antithrombotic therapy in patients with prosthetic heart valves

The thromboembolic events are still an important complication in patients with substitution of any of the heart valves in spite of the advances obtained in the design of prostheses. On reviewing literature, we confirm that the modalities of less intense anticoagulation, with platelet antiaggregant t...

Full description

Bibliographic Details
Main Authors: Fidel Manuel Cáceres Lóriga, Horacio Pérez López, Karel Morlans Hernández
Format: Article
Language:Spanish
Published: ECIMED 2014-03-01
Series:Revista Cubana de Cardiología y Cirugía Cardiovascular
Subjects:
Online Access:http://www.revcardiologia.sld.cu/index.php/revcardiologia/article/view/472
_version_ 1818919240444411904
author Fidel Manuel Cáceres Lóriga
Horacio Pérez López
Karel Morlans Hernández
author_facet Fidel Manuel Cáceres Lóriga
Horacio Pérez López
Karel Morlans Hernández
author_sort Fidel Manuel Cáceres Lóriga
collection DOAJ
description The thromboembolic events are still an important complication in patients with substitution of any of the heart valves in spite of the advances obtained in the design of prostheses. On reviewing literature, we confirm that the modalities of less intense anticoagulation, with platelet antiaggregant treatment or without it , have been efficient and safe in these patients. The recommended oral anticoagulation therapy for biological protheses should attain an international standardized range from 2,0 to 3,0 and of lower intensity than that previously administered to patients with mechanical prostheses.
first_indexed 2024-12-20T01:02:43Z
format Article
id doaj.art-6f46010861c045299256d47ff3628144
institution Directory Open Access Journal
issn 1561-2937
language Spanish
last_indexed 2024-12-20T01:02:43Z
publishDate 2014-03-01
publisher ECIMED
record_format Article
series Revista Cubana de Cardiología y Cirugía Cardiovascular
spelling doaj.art-6f46010861c045299256d47ff36281442022-12-21T19:58:56ZspaECIMEDRevista Cubana de Cardiología y Cirugía Cardiovascular1561-29372014-03-01141353Antithrombotic therapy in patients with prosthetic heart valvesFidel Manuel Cáceres Lóriga0Horacio Pérez LópezKarel Morlans HernándezInstituto de Cardiología y Cirugía Cardiovascular, Calle 17 # 702, esq A, El Vedado, Ciudad de La Habana, Cuba.The thromboembolic events are still an important complication in patients with substitution of any of the heart valves in spite of the advances obtained in the design of prostheses. On reviewing literature, we confirm that the modalities of less intense anticoagulation, with platelet antiaggregant treatment or without it , have been efficient and safe in these patients. The recommended oral anticoagulation therapy for biological protheses should attain an international standardized range from 2,0 to 3,0 and of lower intensity than that previously administered to patients with mechanical prostheses.http://www.revcardiologia.sld.cu/index.php/revcardiologia/article/view/472protesis valvulares cardiacasagentes fibrinoliticos/uso terapéuticoanticoagulantes/uso terapéutico.
spellingShingle Fidel Manuel Cáceres Lóriga
Horacio Pérez López
Karel Morlans Hernández
Antithrombotic therapy in patients with prosthetic heart valves
Revista Cubana de Cardiología y Cirugía Cardiovascular
protesis valvulares cardiacas
agentes fibrinoliticos/uso terapéutico
anticoagulantes/uso terapéutico.
title Antithrombotic therapy in patients with prosthetic heart valves
title_full Antithrombotic therapy in patients with prosthetic heart valves
title_fullStr Antithrombotic therapy in patients with prosthetic heart valves
title_full_unstemmed Antithrombotic therapy in patients with prosthetic heart valves
title_short Antithrombotic therapy in patients with prosthetic heart valves
title_sort antithrombotic therapy in patients with prosthetic heart valves
topic protesis valvulares cardiacas
agentes fibrinoliticos/uso terapéutico
anticoagulantes/uso terapéutico.
url http://www.revcardiologia.sld.cu/index.php/revcardiologia/article/view/472
work_keys_str_mv AT fidelmanuelcaceresloriga antithrombotictherapyinpatientswithprostheticheartvalves
AT horacioperezlopez antithrombotictherapyinpatientswithprostheticheartvalves
AT karelmorlanshernandez antithrombotictherapyinpatientswithprostheticheartvalves